AzTrials
AzTrials

Macular PsudoholeNCT01959802

Foveal Cone Outer Segment Tips Line Defect in Macular Pseudohole

A study testing Vitrectomy in people with Macular Psudohole, run by Kyorin University at 1 site in Japan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Evaluation of recovery in foveal cone outer segment tips line defect and visual acuity after surgery for macular pseudohole Read more about this study

Who is it for?
Ages 10 to 95 years
Conditions the study is for
Macular Psudohole
What is being tested?
Vitrectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteJapan
Study dates
Apr 2008to Mar 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 95 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • The patienst with macular pseudo hole

Who cannot join

  • The patients with follow-up less than 6 months

Trial locations and contacts

1 site in 1 country.

Japan1 site
  • Kyorin Eye Center

    Mitaka, Tokyo, 181-8611

Other trials in Japan

About this study

Official title: Correlation Between Foveal Cone Outer Segment Tips Line Defect and Visual Acuity After Surgery for Macular Pseudohole

Evaluation of recovery in foveal cone outer segment tips line defect and visual acuity after surgery for macular pseudohole

Being tested
Vitrectomy
Keywords
Macular pseudohole, Cone outer segment tips line

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VitrectomyProcedure or surgery

Study groups in NCT01959802
Study groupRoleWhat they receive
VitrectomyOtherVitrectomy for macular pseudo hole
Receives: Procedure: Vitrectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Optical coherence tomography

    Anatomical recovery detected with optical coherence tomography after surgery

    Measured: one year

Secondary outcomes (1)
  1. Visual acuity

    Visual recovery after surgery

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Oct 2013 (estimated)
  2. Study startApr 2008
  3. Primary completionApr 2008
  4. Study completionMar 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01959802
Sponsor's protocol ID
Kyorineye014
Other IDs
Kyorineye014
Status last verified
Oct 2013
First submitted
7 Oct 2013
Last updated
10 Oct 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Vitrectomy in people with Macular Psudohole, run by Kyorin University at 1 site in Japan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Oct 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Japan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Optical coherence tomography (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Oct 2013.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in